GLAXOSMITHKLINE PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Change in Directorate

Download	< Back
28 Oct 2020
Pursuant to Regulation 30 and Schedule Ill (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, we wish to inform you that the Board of Directors at its meeting held on ?28th October 2020 have approved the re-appointment of Ms. Puja Thakur (DIN: 07971789) as a Wholetime Director & Chief Financial Officer (CFO) for period of 3 years from pt January 2021 to 31 st December 2023, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting. Ms. Puja Thakur is not related to any of the existing Directors of the Company and she is not debarred from holding the Office of Director by virtue of any order passed by SEBI<BR> or any other such authority. A brief profile is attached as Annexure A.
View all announcements for GLAXOSMITHKLINE PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us